Genex Infosys PLC announcements
128 Dhaka Stock Exchange announcements for Genex Infosys PLC (GENEXIL) since 2021: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (21).
- Category Change
The company will be placed in 'B' category from existing 'A' category with effect from January 01, 2025 as the company has approved 3% Cash Dividend for the year ended June 30, 2024.
- Emphasis of Matter
The auditor of the company has given the "Emphasis of Matter" paragraphs in the Auditor's Report of the company for the year ended June 30, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/November/GENEXIL_2024.pdf
- Appointment of Chairman
The company has informed that the Board of Directors has appointed Mr. TIM Nurul Kabir as the Chairman of the company with effect from November 24, 2024.
- Resumption after Record date
Trading of the shares of the company will resume on 21.11.2024.
- Suspension for record date
Trading of the shares of the company will remain suspended on record date i.e., 20.11.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 18.11.2024 to 19.11.2024. Trading of the shares of the company will remain suspended on record date i.e., 20.11.2024.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 0.69 for July-September 2024 as against Tk. 0.82 for July-September 2023; Consolidated NOCFPS was Tk. 0.91 for July-September 2024 as against Tk. 1.69 for July-September 2023. Consolidated NAV per share was Tk. 21.23 as on September 30, 2024 and Tk. 20.38 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2024 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
- The Board of Directors has recommended 3\% Cash dividend excluding Sponsors & Directors for the year ended June 30, 2024
The Board of Directors has recommended 3\% Cash dividend excluding Sponsors & Directors for the year ended June 30, 2024. Sponsors\' and Directors\' Shares: 36,195,732. Gross dividend cash amount Tk. 25,276,287.00 will be paid to the general shareholders. Date of AGM: 30.12.2024, Time: 11:00 AM, Venue: Digital Platform subject to the approval of BSEC. Record Date: 20.11.2024. (cont.)
- Dividend Declaration
(Cont. news of GENEXIL): The Company has also reported consolidated EPS of Tk. 2.62, consolidated NAV per share of Tk. 20.38 and consolidated NOCFPS of Tk. 1.85 for the year ended June 30, 2024 as against Tk. 3.19, Tk. 19.24 and Tk. 4.89 respectively for the year ended June 30, 2023. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (28.10.2024) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- Name Change of the Company
Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'Genex Infosys PLC' instead of 'Genex Infosys Limited' with effect from June 02, 2024. Other things (except name) will remain unchanged.
- Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 0.94 for January-March 2024 as against Tk. 0.71 for January-March 2023; Consolidated EPS was Tk. 2.54 for July 2023-March 2024 as against Tk. 3.17 for July 2022-March 2023. Consolidated NOCFPS was Tk. 2.69 for July 2023-March 2024 as against Tk. 4.75 for July 2022-March 2023. Consolidated NAV per share was Tk. 19.75 as on March 31, 2024 and Tk. 19.24 as on June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2024 at 05:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.
- Dividend Disbursement
The company has informed that it has credited the Bonus shares to the respective shareholders' BO Accounts and it has also disbursed the Cash Dividend to the respective shareholders for the year ended June 30, 2023.
- The Company has informed that the Board of Directors has approved an agreement with \"Red Sea Gateway Terminal Banglades
The Company has informed that the Board of Directors has approved an agreement with \"Red Sea Gateway Terminal Bangladesh Limited \"RSGT\" a Saudi Arabian Company\", who is assigned to operate Patenga Container Terminal (PCT) for next 22 years under a concession agreement with Chittagong Port Authority in a G2G Partnership Kingdom of Saudi Arabia. (cont.)
- Agreement with RSGT Bangladesh Ltd. for building IT infrastructure
(Continuation news of GENEXIL): Under the agreement, Genex will build a state-of-the-art turnkey IT infrastructure for RSGT Bangladesh Ltd. at Patenga Container Terminal (PCT). This agreement will generate a revenue of BDT. 28.5 Crore over the next 1 year. (end)
The first part of this announcement is missing from the archive. - Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 0.81 for October-December 2023 as against Tk. 1.20 for October-December 2022. Consolidated EPS was Tk. 1.66 for July-December 2023 as against Tk. 2.56 for July-December 2022. Consolidated NOCFPS was Tk. 2.48 for July-December 2023 as against Tk. 3.11 for July-December 2022. Consolidated NAV per share was Tk. 19.75 as on December 31, 2023 and Tk. 19.24 as on June 30, 2023.
- Declaration of share transfer by a Director
Mr. Prince Mojumder, a Director of the company, has expressed his intention to transfer 4,00,000 shares of the company to his mother Ms. Momota Rani Ray (General Shareholder of the company), by way of gift outside the trading system of the Exchange within next 30 working days from the date of issuance of DSE approval letter issued on December 26, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2024 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.